The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Subscribe To Our Newsletter & Stay Updated
